By speedily dissolving the clot, thrombolytic therapy might help lower the potential risk of prolonged-phrase harm to the veins and improve Over-all results. The documented incidence of PAD and CLI may differ according to the population researched. As many as 21% of sufferers with intermittent claudication may progress to CLI. https://sgvasculargrp.com/medical-condition/peripheral-arterial-disease/